MANNATECH INC Restricted Cash, Current
MANNATECH INC (MTEX) had Restricted Cash, Current of $218.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2026-08-12
- 2026-06-30: Restricted Cash, Current $218.00K.
- 2026-03-31: Restricted Cash, Current $134.00K.
- 2025-12-31: Restricted Cash, Current $550.00K.
- 2025-09-30: Restricted Cash, Current $550.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $218.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $134.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $550.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $550.00K 10-Q · filed 2025-11-12 |
| 2024-12-31 | $550.00K 10-K · filed 2026-04-15 |
| 2023-12-31 | $938.00K 10-K · filed 2025-03-26 |
| 2022-12-31 | $944.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $944.00K 10-K · filed 2024-03-28 |
| 2020-12-31 | $944.00K 10-K · filed 2023-03-17 |
| 2019-12-31 | $943.00K 10-K · filed 2022-03-15 |
| 2019-09-30 | $1.45M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.45M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.51M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $1.51M 10-K · filed 2021-03-19 |
| 2018-09-30 | $1.51M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.51M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $1.51M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.51M 10-K · filed 2020-03-26 |
| 2016-12-31 | $1.51M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |